Cargando…
Long-term omalizumab use in the treatment of exercise-induced anaphylaxis
Reported is a case of a 39-year-old male who was diagnosed with exercise-induced anaphylaxis (EIA). He was initially treated prophylactically with fexofenadine, montelukast, and ranitidine. He also used an epinephrine autoinjector as needed. He was refractory to these medications and continued to ha...
Autores principales: | Peterson, Mark R., Coop, Christopher A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
OceanSide Publications, Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5662542/ https://www.ncbi.nlm.nih.gov/pubmed/29070274 http://dx.doi.org/10.2500/ar.2017.8.0204 |
Ejemplares similares
-
Novel treatment of allergic fungal sinusitis using omalizumab
por: Evans, Martin Oman, et al.
Publicado: (2014) -
Omalizumab: Practical considerations regarding the risk of anaphylaxis
por: Kim, Harold L, et al.
Publicado: (2010) -
Steroid sparing effect of omalizumab in seropositive allergic bronchopulmonary aspergillosis
por: Beam, Keith T., et al.
Publicado: (2015) -
Impact of Omalizumab on Anaphylaxis in Patients Treated for Chronic Urticaria
por: Song, Xiaoting, et al.
Publicado: (2023) -
Severe exercise-induced anaphylaxis in a hot and humid area successfully treated with omalizumab: a case report
por: Mobayed, Hassan, et al.
Publicado: (2023)